Literature DB >> 33322549

Are Follow-Up Blood Cultures Useful in the Antimicrobial Management of Gram Negative Bacteremia? A Reappraisal of Their Role Based on Current Knowledge.

Francesco Cogliati Dezza1, Ambrogio Curtolo1, Lorenzo Volpicelli1, Giancarlo Ceccarelli1, Alessandra Oliva1, Mario Venditti1.   

Abstract

Bloodstream infections still constitute an outstanding cause of in-hospital morbidity and mortality, especially among critically ill patients. Follow up blood cultures (FUBCs) are widely recommended for proper management of Staphylococcus aureus and Candida spp. infections. On the other hand, their role is still a matter of controversy as far as Gram negative bacteremias are concerned. We revised, analyzed, and commented on the literature addressing this issue, to define the clinical settings in which the application of FUBCs could better reveal its value. The results of this review show that critically ill patients, endovascular and/or non-eradicable source of infection, isolation of a multi-drug resistant pathogen, end-stage renal disease, and immunodeficiencies are some factors that may predispose patients to persistent Gram negative bacteremia. An analysis of the different burdens that each of these factors have in this clinical setting allowed us to suggest which patients' FUBCs have the potential to modify treatment choices, prompt an early source control, and finally, improve clinical outcome.

Entities:  

Keywords:  Gram negative bacteremia; antibiotic therapy; critically ill patients; follow-up blood cultures

Year:  2020        PMID: 33322549      PMCID: PMC7764048          DOI: 10.3390/antibiotics9120895

Source DB:  PubMed          Journal:  Antibiotics (Basel)        ISSN: 2079-6382


  33 in total

1.  Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial.

Authors:  Dafna Yahav; Erica Franceschini; Fidi Koppel; Adi Turjeman; Tanya Babich; Roni Bitterman; Ami Neuberger; Nesrin Ghanem-Zoubi; Antonella Santoro; Noa Eliakim-Raz; Barak Pertzov; Tali Steinmetz; Anat Stern; Yaakov Dickstein; Elias Maroun; Hiba Zayyad; Jihad Bishara; Danny Alon; Yonatan Edel; Elad Goldberg; Claudia Venturelli; Cristina Mussini; Leonard Leibovici; Mical Paul
Journal:  Clin Infect Dis       Date:  2019-09-13       Impact factor: 9.079

Review 2.  Clinical management of Staphylococcus aureus bacteremia: a review.

Authors:  Thomas L Holland; Christopher Arnold; Vance G Fowler
Journal:  JAMA       Date:  2014-10-01       Impact factor: 56.272

3.  Economic health care costs of blood culture contamination: A systematic review.

Authors:  Casey Dempsey; Erik Skoglund; Kenneth L Muldrew; Kevin W Garey
Journal:  Am J Infect Control       Date:  2019-02-20       Impact factor: 2.918

4.  Gram-negative septic thrombosis in critically ill patients: A retrospective case-control study.

Authors:  Martina Spaziante; Simone Giuliano; Giancarlo Ceccarelli; Francesco Alessandri; Cristian Borrazzo; Alessandro Russo; Mario Venditti
Journal:  Int J Infect Dis       Date:  2020-02-29       Impact factor: 3.623

Review 5.  Infection Risk and Safety of Corticosteroid Use.

Authors:  Jameel Youssef; Shannon A Novosad; Kevin L Winthrop
Journal:  Rheum Dis Clin North Am       Date:  2015-10-24       Impact factor: 2.670

Review 6.  Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe.

Authors:  M Goto; M N Al-Hasan
Journal:  Clin Microbiol Infect       Date:  2013-03-08       Impact factor: 8.067

7.  Follow-up blood cultures add little value in the management of bacteremic urinary tract infections.

Authors:  HyeJin Shi; Cheol-In Kang; Sun Young Cho; Kyungmin Huh; Doo Ryeon Chung; Kyong Ran Peck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-01-28       Impact factor: 3.267

8.  Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia.

Authors:  Pranita D Tamma; Anna T Conley; Sara E Cosgrove; Anthony D Harris; Ebbing Lautenbach; Joe Amoah; Edina Avdic; Pam Tolomeo; Jacqueleen Wise; Sonia Subudhi; Jennifer H Han
Journal:  JAMA Intern Med       Date:  2019-03-01       Impact factor: 21.873

9.  Risk Factors for Positive Follow-Up Blood Cultures in Gram-Negative Bacilli Bacteremia: Implications for Selecting Who Needs Follow-Up Blood Cultures.

Authors:  Hayato Mitaka; Tessa Gomez; Young Im Lee; David C Perlman
Journal:  Open Forum Infect Dis       Date:  2020-03-28       Impact factor: 3.835

10.  Sending repeat cultures: is there a role in the management of bacteremic episodes? (SCRIBE study).

Authors:  J Brad Wiggers; Wei Xiong; Nick Daneman
Journal:  BMC Infect Dis       Date:  2016-06-13       Impact factor: 3.090

View more
  4 in total

1.  Follow-up Blood Culture Practices for Gram-Negative Bloodstream Infections in Immunocompromised Hosts at a Large Academic Medical Center.

Authors:  Lauren Groft Buzzalino; James Mease; Ciera L Bernhardi; Jacqueline T Bork; J Kristie Johnson; Kimberly C Claeys
Journal:  Open Forum Infect Dis       Date:  2022-04-15       Impact factor: 4.423

2.  Impact of follow up blood cultures on outcomes of patients with community-onset gram-negative bloodstream infection.

Authors:  Rajiv Amipara; Hana Rac Winders; Julie Ann Justo; P Brandon Bookstaver; Joseph Kohn; Majdi N Al-Hasan
Journal:  EClinicalMedicine       Date:  2021-03-30

3.  Association of Follow-up Blood Cultures With Mortality in Patients With Gram-Negative Bloodstream Infections: A Systematic Review and Meta-analysis.

Authors:  Joshua T Thaden; Sarah Cantrell; Michael Dagher; Yazhong Tao; Felicia Ruffin; Stacey A Maskarinec; Stacy Goins; Matthew Sinclair; Joshua B Parsons; Emily Eichenberger; Vance G Fowler
Journal:  JAMA Netw Open       Date:  2022-09-01

4.  Synergistic Meropenem/Vaborbactam Plus Fosfomycin Treatment of KPC Producing K. pneumoniae Septic Thrombosis Unresponsive to Ceftazidime/Avibactam: From the Bench to the Bedside.

Authors:  Alessandra Oliva; Ambrogio Curtolo; Lorenzo Volpicelli; Francesco Cogliati Dezza; Massimiliano De Angelis; Sara Cairoli; Donatella Dell'Utri; Bianca Maria Goffredo; Giammarco Raponi; Mario Venditti
Journal:  Antibiotics (Basel)       Date:  2021-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.